NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

Bristol-Myers Squibb Company BMY | NYSE

$63.64 $0.00 | 0.00%

Next Earnings: Sep 13, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
FWD PE *: 9.9x
Payout Ratio (TTM): 54.9%
52-Week Range: $42.52 - $68.64

* Forward PE is based on street estimates.

10 Year BMY Performance Metrics:

Total Return (with DRIP): 65.1% (5.14% CAGR)
Total Return (no DRIP): 51.6% (4.25% CAGR)
Share Price: 14.5% (1.36% CAGR)
Yield on Cost (with DRIP): 6.54%
Total Invested: $10,000
Total Value (with DRIP): $16,508
Total Return $ (with DRIP): $6,508
Dividend Increase: 61.5% (5.05% CAGR)
Dividend Yield (FWD): 3.96% ($2.52)
BMY 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

BMY Share Price chart

Share Price
BMY Price CAGR:1Y: 33.87%2Y: 14.44%5Y: 0.16%10Y: 1.23%
BMY Dividend Charts
BMY - Dividends
BMY Dividend CAGR:1Y: 1.61%2Y: 2.47%5Y: 5.15%10Y: 5.19%
BMY - Dividend Payout Ratio
BMY - Dividend to Free Cash Flow Ratio

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

BMY Earnings, Revenue, Cash & Debt, Shares Outstanding:

BMY - Revenue
BMY Revenue CAGR:1Y: 5.74%2Y: 3.12%5Y: 2.08%10Y: 10.29%
BMY - Earnings Per Share (EPS)
BMY EPS CAGR:1Y: 153.13%2Y: 39.71%5Y: 28.08%10Y: 8.91%
BMY - Net Income
BMY Net Income CAGR:1Y: 153.21%2Y: 40.51%5Y: 25.75%10Y: 11.02%
BMY - EBITDA
BMY EBITDA CAGR:1Y: 50.29%2Y: 5.92%5Y: 1.08%10Y: 12.60%
BMY - Free Cash Flow
BMY Free Cash Flow CAGR:1Y: -13.16%2Y: 22.32%5Y: 1.62%10Y: 35.32%
BMY - Free Cash Flow / Share
BMY Free Cash Flow / Share CAGR:1Y: -13.46%2Y: 21.87%5Y: 3.39%10Y: 32.62%
BMY - Operating Income
BMY Operating Income CAGR:1Y: -0.75%2Y: 55.45%5Y: 13.87%10Y: 11.16%
BMY - Gross Profit
BMY Gross Profit CAGR:1Y: 14.58%2Y: 1.74%5Y: -0.01%10Y: 9.70%
BMY - Shares Outstanding
BMY Shares Outstanding CAGR:1Y: 0.49%2Y: 0.47%5Y: -1.88%10Y: 2.01%
BMY - Share Buybacks
BMY Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BMY - Stock-Based Comp
BMY Stock-Based Comp CAGR:1Y: -1.46%2Y: 3.92%5Y: -2.97%10Y: 9.60%
BMY - Expenses
BMY Expenses CAGR:1Y: -15.51%2Y: 7.89%5Y: 7.75%10Y: 1.57%
BMY - Revenue vs Net Income
BMY - EPS vs FCF / Share
BMY - EPS vs PE Ratio
BMY - FCF vs FCF / Share
BMY - FCF vs Stock Based Comp
BMY - Cash & Debt
BMY - Revenue by Segment
BMY Revenue CAGR:1Y: 5.74%2Y: 3.12%5Y: 2.08%10Y: 10.29%
BMY - Revenue by Region
BMY Revenue CAGR:1Y: 5.74%2Y: 3.12%5Y: 2.08%10Y: 10.29%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BMY - REVENUE: Actual + Estimates
BMY Actual Revenue CAGR:1Y: 5.74%2Y: 3.12%5Y: 2.08%10Y: 10.29%
BMY - EPS: Actual + Estimates
BMY Actual EPS CAGR:1Y: 153.13%2Y: 39.71%5Y: 28.08%10Y: 8.91%
BMY - NET INCOME: Actual + Estimates
BMY Actual Net Income CAGR:1Y: 153.21%2Y: 40.51%5Y: 25.75%10Y: 11.02%
BMY - EBITDA: Actual + Estimates
BMY Actual EBITDA CAGR:1Y: 50.29%2Y: 5.92%5Y: 1.08%10Y: 12.60%

Ratios, Profit Margins & Return on Capital:

BMY - Net Profit Margin
BMY Net Profit Margin CAGR:1Y: 139.42%2Y: 36.27%5Y: 23.20%10Y: 0.66%
BMY - Gross Profit Margin
BMY Gross Profit Margin CAGR:1Y: 8.36%2Y: 13.08%5Y: -2.05%10Y: -0.54%
BMY - Price to Earnings
BMY - Price To Sales Ratio
BMY - Return on Capital Employed
BMY - Return on Invested Capital

Compare stocks side-by-side
 

BMY Dividends Info:

Annual Dividend: $2.52
Forward Yield: 3.96%
Ex-Dividend Date: 2026-07-02
Lifetime Dividends / Share: $50.74

BMY Dividend History: Dates, Payments & Yield list

Below is a schedule of all BMY dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
07/02/202608/03/2026$0.6304.34%3.85%$65.47
04/02/202605/01/2026$0.6304.23%4.33%$58.22
01/02/202602/02/2026$0.6304.71%4.51%$55.89
10/03/202511/03/2025$0.6205.46%5.39%$46.02
07/03/202508/01/2025$0.6205.29%5.61%$44.23
04/04/202505/01/2025$0.6204.48%5%$49.61
01/03/202502/03/2025$0.6204.38%4.14%$59.95
10/04/202411/01/2024$0.6004.45%4.42%$54.32
07/05/202408/01/2024$0.6006.05%4.98%$48.17
05/06/202406/03/2024$0.5004.56%4.79%$41.77
04/04/202405/01/2024$0.6004.67%5.43%$44.21
01/04/202402/01/2024$0.6004.61%4.93%$48.67
10/05/202311/01/2023$0.5704.04%4.45%$51.28
07/06/202308/01/2023$0.5703.59%3.71%$61.53
04/06/202305/01/2023$0.5703.22%3.33%$68.40
01/05/202302/01/2023$0.5703.17%3.2%$71.23
10/06/202211/01/2022$0.5403.08%2.78%$77.70
06/30/202208/01/2022$0.5402.81%2.93%$73.62
03/31/202205/02/2022$0.5402.96%2.88%$75.08
01/06/202202/01/2022$0.5403.51%3.31%$65.19
09/30/202111/01/2021$0.4903.31%3.34%$58.68
07/01/202108/02/2021$0.4902.94%2.88%$68.02
03/31/202105/03/2021$0.4903.1%3.09%$63.48
12/31/202002/01/2021$0.4903.16%3.15%$62.21
10/01/202011/02/2020$0.4503.01%3.03%$59.49
07/02/202008/03/2020$0.4503.04%3.05%$59.10
04/02/202005/01/2020$0.4503.26%2.99%$60.26
01/02/202002/03/2020$0.4502.84%2.83%$63.58
10/03/201911/01/2019$0.4103.31%2.87%$57.16
07/03/201908/01/2019$0.4103.52%3.63%$45.20
04/04/201905/01/2019$0.4103.51%3.52%$46.58
01/03/201902/01/2019$0.4103.63%3.29%$49.89
10/04/201811/01/2018$0.4002.57%3.07%$52.13
07/05/201808/01/2018$0.4002.86%2.68%$59.62
04/05/201805/01/2018$0.4002.57%3.04%$52.69
01/04/201802/01/2018$0.4002.59%2.55%$62.80
10/05/201711/01/2017$0.3902.45%2.51%$62.16
07/05/201708/01/2017$0.3902.77%2.78%$56.11
04/05/201705/01/2017$0.3902.94%2.77%$56.31
01/04/201702/01/2017$0.3902.64%3.16%$49.29
10/05/201611/01/2016$0.3802.77%2.99%$50.80
06/29/201608/01/2016$0.3802.08%2%$76.19
03/30/201605/02/2016$0.3802.4%2.11%$71.96
12/30/201502/01/2016$0.3802.19%2.5%$60.82
09/30/201511/02/2015$0.3702.5%2.25%$65.75
07/01/201508/03/2015$0.3702.19%2.27%$65.34
04/01/201505/01/2015$0.3702.33%2.29%$64.66
12/30/201402/02/2015$0.3702.49%2.46%$60.23
10/01/201411/03/2014$0.3602.85%2.49%$57.80
07/01/201408/01/2014$0.3602.99%2.89%$49.81
04/02/201405/01/2014$0.3602.79%2.91%$49.52
12/31/201302/03/2014$0.3602.71%2.96%$48.64
10/02/201311/01/2013$0.3502.98%2.67%$52.48
07/02/201308/01/2013$0.3503.18%3.18%$43.99
04/03/201305/01/2013$0.3503.41%3.52%$39.72
01/02/201302/01/2013$0.3504.28%3.79%$36.91
10/03/201211/01/2012$0.3404.05%4.06%$33.48
07/03/201208/01/2012$0.3403.9%3.82%$35.60
04/03/201205/01/2012$0.3404.02%4.06%$33.52
01/04/201202/01/2012$0.3403.96%4.19%$32.43
10/06/201111/01/2011$0.3304.07%4.22%$31.31
06/29/201108/01/2011$0.3304.63%4.62%$28.55
03/30/201105/02/2011$0.3304.99%4.64%$28.45
01/05/201102/01/2011$0.3305.07%5.22%$25.27
09/29/201011/01/2010$0.3204.68%4.73%$27.07
06/30/201008/02/2010$0.3205.13%5.01%$25.53
03/30/201005/03/2010$0.3204.78%5.09%$25.13
12/30/200902/01/2010$0.3205%5.25%$24.38
09/30/200911/02/2009$0.3105.51%5.7%$21.77
07/01/200908/03/2009$0.3106.13%5.68%$21.83
04/01/200905/01/2009$0.3105.64%6.43%$19.29
12/30/200802/02/2009$0.3105.42%5.64%$21.99
10/01/200811/03/2008$0.3105.96%6.03%$20.55
07/02/200808/01/2008$0.3106.02%5.87%$21.11
04/02/200805/01/2008$0.3105.72%5.41%$22.94
01/02/200802/01/2008$0.3104.75%5.18%$23.96
10/03/200711/01/2007$0.2803.77%3.84%$29.16
07/03/200708/01/2007$0.2803.53%3.91%$28.67
04/03/200705/01/2007$0.2804.07%3.91%$28.68
01/03/200702/01/2007$0.2804.25%3.89%$28.80
10/04/200611/01/2006$0.2804.55%4.55%$24.62
07/05/200608/01/2006$0.2804.44%4.71%$23.80
04/05/200605/01/2006$0.2804.56%4.48%$25.00
01/04/200602/01/2006$0.2804.95%4.87%$23.02
10/05/200511/01/2005$0.2804.83%5.33%$21.03
06/29/200508/01/2005$0.2804.44%4.47%$25.04
03/30/200505/02/2005$0.2804.39%4.29%$26.08
01/05/200502/01/2005$0.2804.52%4.73%$23.66
09/29/200411/01/2004$0.2804.69%4.79%$23.36
06/30/200408/02/2004$0.2804.57%4.84%$23.16
03/31/200405/03/2004$0.2804.62%4.37%$25.61
12/30/200302/02/2004$0.2803.94%3.92%$28.57
10/01/200311/03/2003$0.2804.3%4.42%$25.36
07/01/200308/01/2003$0.2804.12%4.33%$25.87
04/02/200305/01/2003$0.2805.1%4.39%$25.54
12/31/200202/03/2003$0.2804.84%4.71%$23.80
10/02/200211/01/2002$0.2804.84%4.44%$25.21
07/02/200208/01/2002$0.2804.59%4.95%$22.61
04/03/200205/01/2002$0.2802.97%3.77%$29.68
01/02/200202/01/2002$0.2802.2%2.52%$44.50
10/03/200111/01/2001$0.2751.94%2.03%$54.26
07/03/200108/01/2001$0.2622.05%1.9%$55.19
04/04/200105/01/2001$0.2621.94%1.99%$52.74
01/03/200102/01/2001$0.2621.65%1.74%$60.08
10/04/200011/01/2000$0.2331.77%1.55%$60.32
07/05/200008/01/2000$0.2331.66%1.88%$49.55
04/05/200005/01/2000$0.2331.52%1.9%$49.02
01/05/200002/01/2000$0.2331.66%1.52%$61.51
09/29/199911/01/1999$0.2051.31%1.11%$73.52
06/30/199908/02/1999$0.2061.23%1.3%$63.47
03/30/199905/03/1999$0.2051.33%1.3%$62.76
01/06/199902/01/1999$0.2051.31%1.34%$61.30
09/30/199811/02/1998$0.1861.5%1.41%$52.73
06/30/199808/03/1998$0.1861.36%1.39%$53.45
04/01/199805/01/1998$0.1861.47%1.47%$50.44
12/30/199702/02/1998$0.1861.64%1.52%$48.75
10/01/199711/03/1997$0.1811.84%1.68%$43.16
07/01/199708/01/1997$0.1811.87%1.95%$37.03
04/02/199705/01/1997$0.1812.51%2.33%$30.99
12/31/199602/07/1997$0.1812.79%2.4%$30.16
10/02/199611/01/1996$0.1783.08%2.82%$25.31
07/02/199608/01/1996$0.1783.35%3.39%$21.06
04/02/199605/01/1996$0.1783.47%3.65%$19.57
01/03/199602/01/1996$0.1783.58%3.4%$21.00
10/04/199511/01/1995$0.1763.89%3.83%$18.41
07/05/199508/01/1995$0.1764.39%4.3%$16.39
04/03/199505/01/1995$0.1764.76%4.55%$15.47
12/30/199402/01/1995$0.1765.11%4.86%$14.48
10/03/199411/01/1994$0.1745.14%5.01%$13.86
06/27/199408/01/1994$0.1745.43%5.48%$12.67
03/25/199405/02/1994$0.1745.63%5.26%$13.21
01/03/199402/01/1994$0.1745.08%5.05%$13.77
09/27/199311/01/1993$0.1715.03%4.88%$14.04
06/28/199308/02/1993$0.1714.93%5.36%$12.79
03/29/199305/03/1993$0.1714.94%4.65%$14.75
01/04/199302/01/1993$0.1714.34%4.84%$14.16
09/28/199211/02/1992$0.1644.41%4.01%$16.39
06/26/199208/03/1992$0.1644.24%3.91%$16.80
03/30/199205/01/1992$0.1643.53%3.69%$17.79
12/27/199102/03/1992$0.1643.25%3.45%$19.04
09/30/199111/01/1991$0.1432.9%2.77%$20.61
06/28/199108/01/1991$0.1433.09%2.84%$20.14
04/01/199104/03/1991$0.1433.12%3.08%$18.53
12/28/199002/01/1991$0.1433.6%3.49%$16.36
10/01/199011/01/1990$0.1263.49%3.58%$14.10
06/29/199008/01/1990$0.1263.35%3.26%$15.47
04/02/199005/01/1990$0.1263.98%3.77%$13.38
12/29/198902/01/1990$0.1263.79%3.97%$12.70
09/19/198911/01/1989$0.1194.06%3.7%$12.85
06/30/198908/01/1989$0.1194.18%4.15%$11.48
04/03/198905/01/1989$0.1194.26%4.09%$11.63
12/30/198802/01/1989$0.1194.42%4.36%$10.92
10/03/198811/01/1988$0.1003.82%3.77%$10.59
06/27/198808/01/1988$0.1004.23%3.88%$10.29
03/25/198805/02/1988$0.1003.99%4.16%$9.61
01/04/198802/01/1988$0.1003.88%3.82%$10.47
09/28/198711/02/1987$0.0832.73%3.22%$10.35
06/26/198708/03/1987$0.0832.73%2.79%$11.96
03/30/198705/01/1987$0.0832.79%2.87%$11.60
12/26/198602/02/1987$0.0833.3%2.99%$11.15
09/29/198610/01/1986$0.0653.04%3.08%$8.51
06/27/198607/02/1986$0.0652.51%2.55%$10.28
12/27/198501/01/1986$0.0562.86%2.86%$7.82
09/30/198510/02/1985$0.0563.48%3.38%$6.62
06/28/198507/03/1985$0.0563.06%3.1%$7.21
03/29/198504/03/1985$0.0563.27%3.28%$6.81
12/28/198401/02/1985$0.0483.06%3.12%$6.10
10/01/198410/03/1984$0.0483.56%3.56%$5.34
06/29/198407/04/1984$0.0483.41%3.53%$5.40
04/02/198404/04/1984$0.0483.49%3.49%$5.46
12/30/198301/04/1984$0.0360%2.75%$5.19
10/03/198310/05/1983$0.0360%2.75%$5.19
07/01/198307/06/1983$0.0360%2.75%$5.19
04/04/198304/06/1983$0.0360%2.75%$5.19
01/03/198301/05/1983$0.0310%2.41%$5.19
10/04/198210/06/1982$0.0310%2.41%$5.19
07/02/198207/07/1982$0.0310%2.41%$5.19
04/02/198204/07/1982$0.0310%2.41%$5.19
01/04/198201/06/1982$0.0270%2.11%$5.19
10/05/198110/07/1981$0.0270%2.11%$5.19
07/06/198107/08/1981$0.0270%2.11%$5.19
05/01/198105/06/1981$0.0240%1.83%$5.19
04/06/198104/08/1981$0.0270%2.11%$5.19
10/06/198010/08/1980$0.0240%1.83%$5.19
06/30/198007/02/1980$0.0240%1.83%$5.19
03/28/198004/02/1980$0.0240%1.83%$5.19
12/28/197901/02/1980$0.0210%1.65%$5.19
10/05/197910/10/1979$0.0210%1.65%$5.19
06/29/197907/04/1979$0.0210%1.65%$5.19
04/02/197904/04/1979$0.0210%1.65%$5.19
12/29/197801/03/1979$0.0180%1.4%$5.19
10/02/197810/04/1978$0.0180%1.4%$5.19
06/30/197807/05/1978$0.0180%1.4%$5.19
03/31/197804/05/1978$0.0180%1.4%$5.19
12/30/197701/04/1978$0.0160%1.26%$5.19
10/03/197710/05/1977$0.0160%1.26%$5.19
06/27/197706/29/1977$0.0160%1.26%$5.19
03/30/197704/01/1977$0.0160%1.26%$5.19
12/29/197612/31/1976$0.0130%1.03%$5.19
09/28/197609/30/1976$0.0130%1.03%$5.19
06/28/197606/30/1976$0.0130%1.03%$5.19
03/29/197603/31/1976$0.0130%1.03%$5.19
12/26/197512/31/1975$0.0130%1.03%$5.19
09/29/197510/01/1975$0.0120%0.92%$5.19
06/27/197507/02/1975$0.0120%0.92%$5.19
03/31/197504/02/1975$0.0120%0.92%$5.19
12/27/197401/01/1975$0.0110%0.87%$5.19
09/30/197410/02/1974$0.0110%0.87%$5.19
06/28/197407/03/1974$0.0110%0.87%$5.19
03/28/197404/01/1974$0.0110%0.87%$5.19
12/28/197301/02/1974$0.0100%0.76%$5.19
10/01/197310/03/1973$0.0100%0.76%$5.19
07/30/197308/01/1973$0.0100%0.76%$5.19
04/30/197305/02/1973$0.0100%0.76%$5.19
01/29/197301/31/1973$0.0090%0.69%$5.19
10/31/197211/02/1972$0.0090%0.69%$5.19
07/26/197207/28/1972$0.0090%0.69%$5.19

Projected Future Returns & Dividends for BMY

Based on past 10-year performance, here are BMY growth metrics:

Share price CAGR of +1.23%
Dividend CAGR of +5.19%

Using BMY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

BMY (DRIP)BMY - No DRIP
Current Price$63.64$63.64
Start Shares157.13157.13
Start Value$10,000$10,000
  
After 10 years:
Final Share Count233.02157.13
Dividends Payment$0.71$0.71
Annual Dividends$664$447
Yield on cost6.64%4.47%
Share Price$71.91$71.91
Total Dividends$5,126$4,186
Final Value$16,757$15,486

Estimated Future Value + Dividends - BMY

NOTE: Above numbers are our estimate based on BMY's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)

Company Info

Bristol-Myers Squibb Company (BMY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.

BMY website: https://www.bms.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
Pro
$171/yr ($14.25/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $57/yr (25%)
Most Popular
Premium
$288/yr ($24/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $96/yr (25%)
Ultra
$576/yr ($48/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $192/yr (25%)